As of 2025-07-09, the EV/EBITDA ratio of Thalys Medical Technology Group Inc (603716.SS) is -48.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 603716.SS's latest enterprise value is 3,197 mil CNY. 603716.SS's TTM EBITDA according to its financial statements is -66 mil CNY. Dividing these 2 quantities gives us the above 603716.SS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing EV/EBITDA multiples | 23.1x - 27.8x | 27.2x |
Forward EV/EBITDA multiples | 10.4x - 19.3x | 14.7x |
Fair Price | (19.15) - (1.08) | (11.42) |
Upside | -190.4% - -105.1% | -153.9% |
(CNY in millions except Fair Price) | |||
Trailing | Forward | ||
Market Cap (CNY mil) | EV/EBITDA | EV/EBITDA | |
Thalys Medical Technology Group Inc | 2,476 | N/A | 103.8x |
Shenzhen Weiguang Biological Products Co Ltd | 6,593 | 21.8x | 8.9x |
Boya Bio-pharmaceutical Group Co Ltd | 13,181 | 33.7x | 20.8x |
Beijing Strong Biotechnologies Inc | 8,237 | 13.8x | 11.1x |
MedicalSystem Biotechnology Co Ltd | 4,162 | 16.3x | 7.3x |
Vcanbio Cell & Gene Engineering Corp Ltd | 12,518 | 79.4x | 35.2x |
Getein Biotech Inc | 4,113 | 24x | 9.3x |
Qingdao Vland Biotech INC | 3,401 | 27.2x | 7.8x |
Beijing Balance Medical Technology Co Ltd | 13,755 | 81.8x | 42.1x |
Xiamen Amoytop Biotech Co Ltd | 28,399 | 28.8x | 18.3x |
Industry median | 27.2x | 14.7x | |
(*) EBITDA | -66 | 31 | |
Enterprise value | (1,783) | 453 | |
(-) Net debt | 721 | 721 | |
Equity value | -2,505 | -268 | |
(/) Outstanding shares | 117 | 117 | |
Fair price | -21 | -2 | |
April 16, 2025 | -28.12 |
April 15, 2025 | -28.92 |
April 14, 2025 | -28.71 |
April 11, 2025 | -28.58 |
April 10, 2025 | -28.09 |
April 09, 2025 | -27.66 |
April 08, 2025 | -27.03 |
April 07, 2025 | -28.09 |
April 03, 2025 | -29.97 |
April 02, 2025 | -31.24 |
April 01, 2025 | -30.06 |
March 31, 2025 | -29.48 |
March 28, 2025 | -30.3 |
March 27, 2025 | -31.17 |
March 26, 2025 | -31.6 |
March 25, 2025 | -32.52 |
March 24, 2025 | -30.97 |
March 21, 2025 | -31.99 |
March 20, 2025 | -33.56 |
March 19, 2025 | -34.88 |
March 18, 2025 | -34.16 |
March 17, 2025 | -33.79 |
March 14, 2025 | -34.91 |
March 13, 2025 | -37.05 |
March 12, 2025 | -34.68 |
March 11, 2025 | -32.52 |
March 10, 2025 | -30.56 |
March 07, 2025 | -28.78 |
March 06, 2025 | -29.26 |
March 05, 2025 | -28.94 |
March 04, 2025 | -29.67 |
March 03, 2025 | -28.83 |
February 28, 2025 | -27.21 |
February 27, 2025 | -28.12 |
February 26, 2025 | -28.51 |
February 25, 2025 | -29.12 |
February 24, 2025 | -29.33 |
February 21, 2025 | -30.19 |
February 20, 2025 | -30.74 |
February 19, 2025 | -30.1 |
February 18, 2025 | -30.71 |
February 17, 2025 | -30.01 |
February 14, 2025 | -28.28 |
February 13, 2025 | -26.71 |
February 12, 2025 | -27.73 |
February 11, 2025 | -27.27 |
February 10, 2025 | -27.82 |
February 07, 2025 | -26.29 |
February 06, 2025 | -24.9 |
February 05, 2025 | -24.56 |